SPOTLIGHT -
The industry has witnessed a general decline in HMO enrollment in thepast year, and when rates of growth (see chart, facing page) are studied,the plans that are growing are not adding millions of enrollees, analystssay.
Study Reveals Association Between Adult Male Exposure to Insecticides, Decline in Sperm Concentration
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
The potential promise of prescription digital therapeutics in mental health disorders
AI Improving Healthcare Efficiency, the Evolution of VBC, Reducing Healthcare Waste and More With William Shrank of Andreessen Horowitz
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Clinical Trial Begins of Gene Therapy for Parkinson-Like Disease
A new gene therapy administered directly to the brain aims to preserve dopamine neurotransmission in patients with multiple system atrophy.
Impact of 2025’s IRA Out-of-Pocket Cap on Medicare Part D Beneficiaries
Prior to the IRA, there were no limits on beneficiary OOP spending throughout the year. However, by 2025 the IRA will introduce the $2,000 maximum OOP expenses.